Materials related to the Covidien - Medtronic merger
Proxy Statement
Information Statement
Information Statement
Information Statement
This is important, because:
EU Approves Medtronics Merger With Covidien
Green Light Comes Two Days After U.S. Authorities Cleared $43 Billion Deal
By Tom Fairless
Nov. 28, 2014 6:12 a.m. ET
BRUSSELSMedical-device maker Medtronic Inc. secured European Union approval Friday for its $43 billion merger with rival Covidien PLC of Ireland, subject to conditions, two days after U.S. authorities cleared the deal.
....
The merger, combining two of the worlds largest surgical-implant and hospital-supply companies, remains on schedule to close in early 2015, Chief Executive Omar Ishrak said this month. The companies plan to hold a special meeting in January to seek shareholder approval of the merger.
Medtronics plan to buy Covidien, based in Dublin, has drawn scrutiny over a tax tactic criticized by U.S. government officials. The acquisition plan involves Medtronic reincorporating from Minneapolis to Ireland, which would lighten the companys tax burden.
Alan Zibel in Washington contributed to this article.
Write to Tom Fairless at tom.fairless@wsj.com